Chemoinformaics analysis of Scuterivulactone D
Molecular Weight | 470.562 | nRot | 4 |
Heavy Atom Molecular Weight | 436.29 | nRig | 24 |
Exact Molecular Weight | 470.23 | nRing | 4 |
Solubility: LogS | -4.076 | nHRing | 1 |
Solubility: LogP | 3.178 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 1 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
nHA | 7 | APOL | 73.375 |
nHD | 3 | BPOL | 39.317 |
QED | 0.5 |
Synth | 5.006 |
Natural Product Likeliness | 1.556 |
NR-PPAR-gamma | 0.614 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.047 |
Pgp-sub | 0.766 |
HIA | 0.02 |
CACO-2 | -5.213 |
MDCK | 0.0000148 |
BBB | 0.846 |
PPB | 0.965556 |
VDSS | 0.76 |
FU | 0.0676466 |
CYP1A2-inh | 0.178 |
CYP1A2-sub | 0.205 |
CYP2c19-inh | 0.09 |
CYP2c19-sub | 0.156 |
CYP2c9-inh | 0.295 |
CYP2c9-sub | 0.842 |
CYP2d6-inh | 0.158 |
CYP2d6-sub | 0.106 |
CYP3a4-inh | 0.605 |
CYP3a4-sub | 0.277 |
CL | 10.163 |
T12 | 0.728 |
hERG | 0.232 |
Ames | 0.005 |
ROA | 0.554 |
SkinSen | 0.599 |
Carcinogencity | 0.09 |
EI | 0.307 |
Respiratory | 0.957 |
NR-Aromatase | 0.84 |
Antiviral | Yes |
Prediction | 0.914905 |